U.S. market Closed. Opens in 1 hour 55 minutes

PRME | Prime Medicine, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/A5.21MN/A
Cost of Revenue147.91MN/AN/AN/A2.76M
Gross Profit-147.91MN/AN/AN/A-2.76M
Operating Expenses186.64M116.54M84.47M6.14M2.17M
Selling, General & Admin38.73M29.82M13.92M3.16M1.25M
Research & Development147.91M86.72M70.55M2.98M920.00K
Other Operating Expenses13.50M1.90M-80.99M-11.48MN/A
Operating Income-191.29M-116.54M-84.47M-932.00K-2.17M
Other Expenses / Income-7.12M-6.22M-81.38M-611.00K-353.00K
Before Tax Income-198.41M-122.77M-165.85M-1.54M-2.52M
Income Tax Expenses-279.00K-948.00K-486.00K1.87M4.00K
Net Income-198.13M-121.82M-165.37M-3.41M-2.53M
Interest ExpensesN/A12.13MN/AN/AN/A
Basic Shares Outstanding90.97M97.21M64.90M71.80M95.73M
Diluted Shares Outstanding90.97M97.21M64.90M71.80M95.73M
EBITDA-186.64M-108.42M-83.52M-11.76M-2.17M
EBITDA Margin0.00%0.00%0.00%-225.64%0.00%
EBIT-198.41M-110.64M-165.85M-1.54M-2.52M
EBIT Margin0.00%0.00%0.00%-29.62%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙